191 related articles for article (PubMed ID: 33504017)
1. Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis.
Nakamura K; Hiyake N; Hamada T; Yokoyama S; Mori K; Yamashiro K; Beppu M; Sagara Y; Sagara Y; Sugiura T
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33504017
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
3. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
4. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
6. A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa.
Mehterov N; Sacconi A; Pulito C; Vladimirov B; Haralanov G; Pazardjikliev D; Nonchev B; Berindan-Neagoe I; Blandino G; Sarafian V
Front Oncol; 2022; 12():1072579. PubMed ID: 36531016
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia.
Shen Y; Ding Y; Ma Q; Zhao L; Guo X; Shao Y; Niu C; He Y; Zhang F; Zheng D; Wei W; Liu F
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1212-1220. PubMed ID: 30988139
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
11. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
[TBL] [Abstract][Full Text] [Related]
12. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
13. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
14. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma.
Scholtz B; Horváth J; Tar I; Kiss C; Márton IJ
Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215172
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma.
Wu J; Cao J; Li X; Wu B; Zhang S
Arch Oral Biol; 2020 Aug; 116():104732. PubMed ID: 32445972
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
18. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
19. Salivary miR-30c-5p as Potential Biomarker for Detection of Oral Squamous Cell Carcinoma.
Mehterov N; Vladimirov B; Sacconi A; Pulito C; Rucinski M; Blandino G; Sarafian V
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572265
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
